GILUPI GmbH
Hermannswerder 20a
Potsdam
14473
Germany
Tel: 49-331-5818478-2
Fax: 49-331-5818478-0
Website: http://www.gilupi.com/
Email: info@gilupi.com
About GILUPI GmbH
GILUPI is a medical device company with focus on the development and production of new innovative products for the in vivo isolation of rare cells from the circulation. These products are based on a unique patented technology. Currently, the main focus of GILUPI is the diagnostics market for cancer.YEAR FOUNDED:
2006
LEADERSHIP:
CEO: Jens Pfannkuche
JOBS:
Please click here for GILUPI job opporrtunities.
7 articles about GILUPI GmbH
-
GILUPI Names Industry Vet as New CEO
1/18/2018
Dr. Jurinke has about 20 years of biomedical industry experience in technical and commercial positions. -
Molecular Characterization of Circulating Tumor Cells isolated with GILUPI Technology from Prostate Cancer Patients
12/14/2017
GILUPI GmbH announces the recent publication of a clinical study demonstrating multiplex gene expression profiling of cTCs isolated in vivofrom high-risk prostate cancer patients by the use of GILUPI CellCollector.
-
Early Lung Cancer Screening With CTC Detection Using the GILUPI Cellcollector and Low-Dose Computed Tomography
11/1/2017
Yutong He and colleagues from the Fourth Hospital of Hebei Medical University in China investigated if combining to methods – Low-Dose Computed Tomography (LDCT) and enumeration of CTCs using the GILUPI CellCollector® - improves early detection of lung cancer.
-
GILUPI Will Attend At The ACTC Congress In Rhodos
9/21/2017
-
In Vivo Detection Of CTCs In Head And Neck Cancer Patients Using The GILUPI CellCollector
9/7/2017
-
Detection Of Circulating Tumor Cells In Breast Cancer Patients Using The GILUPI CellCollector
8/9/2017
-
GILUPI Release: Approval For German Medical Device In China
7/7/2017